VAL-301 (ValiRx)

N/A

Report date: 2024/07/03 18:05:46

NME

Base Information

Drug NameVAL-301 (ValiRx)

Drug Alias NameVAL-301 (ValiRx)

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionSRC inhibitors

TargetsSRC

Therapy Area/IndicationsEndometriosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesValirx Plc

China Registration ClassN/A

Develop Information

Active CompaniesValirx Plc

Inactive CompaniesN/A

Active IndicationsEndometriosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A